Capital Export orchestrates a primary MBO of Verdot IPS²
Capital Export, an investment fund that specializes in supporting exporting companies, has completed a primary MBO of Verdot IPS². This French company designs equipment for the pharmaceutical industry (Big Pharma, biotechs, etc.) to extract the active ingredients needed to produce drugs and vaccines. Capital Export is the majority shareholder, with contributions from Éric Merlot (current CEO), Swen Capital, CEPAL Capital (Caisse d’Epargne Auvergne-Limousin), and CELDA Capital (Caisse d’Epargne Loire-Drôme-Ardèche).